Corporate Presentation

Download Presentation


OKYO Pharma reaches milestone with first patient screening for dry eye disease trial

OKYO Pharma granted new patent for OK-101 to treat neuropathic pain

OKYO Pharma to take dry eye disease drug direct into Phase 2 clinical trials

OKYO CEO Gary Jacob talks to Jane King about the progress of the phase 2 trial with OK-101